Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J T Safrit

Showing results (1-10 of 25) with videos related to

Pageof 3
Sort By:
Cancer Immunology, Immunotherapy : CII|January 1, 1992
Hierarchy of in vitro sensitivity and resistance of tumor cells to cytotoxic effector cells, cytokines, drugs and toxinsJ T Safrit, B Bonavida
Cancer Research|December 1, 1992
Sensitivity of resistant human tumor cell lines to tumor necrosis factor and adriamycin used in combination: correlation between down-regulation of tumor necrosis factor-messenger RNA induction and overcoming resistanceJ T Safrit, B Bonavida
Current Opinion in Immunology|August 1, 1995
The immunology of primary HIV infection: which immune responses control HIV replication?J T Safrit, R A Koup
Journal of Immunology (Baltimore, Md. : 1950)|October 15, 1991
Synergistic effect of tumor necrosis factor-alpha- and diphtheria toxin-mediated cytotoxicity in sensitive and resistant human ovarian tumor cell linesH Morimoto, J T Safrit, B Bonavida
The Journal of Urology|May 1, 1993
Sensitivity of human renal cell carcinoma lines to TNF, adriamycin, and combination: role of TNF mRNA induction in overcoming resistanceJ T Safrit, A Belldegrun, B Bonavida
Gynecologic Oncology|February 1, 1993
Sensitivity of drug-resistant human ovarian tumor cell lines to combined effects of tumor necrosis factor (TNF-alpha) and doxorubicin: failure of the combination to modulate the MDR phenotypeJ T Safrit, J S Berek, B Bonavida
AIDS (London, England)|January 1, 1997
New observations on cellular immune responses to HIV and T-cell epitopesF M Gotch, R A Koup, J T Safrit
Journal of Immunology (Baltimore, Md. : 1950)|October 15, 1994
A region of the third variable loop of HIV-1 gp120 is recognized by HLA-B7-restricted CTLs from two acute seroconversion patientsJ T Safrit, A Y Lee, C A Andrews, et al.
Seminars in Immunology|August 1, 1996
Defining antibody protection against HIV-1 transmission in Hu-PBL-SCID miceR A Koup, J T Safrit, R Weir, et al.
The Journal of Infectious Diseases|May 1, 1995
Pre- and postexposure protection against human immunodeficiency virus type 1 infection mediated by a monoclonal antibodyM C Gauduin, J T Safrit, R Weir, et al.
Pageof 3

Showing results (1-10 of 25) with videos related to

Sort By:
Pageof 3
Cancer Immunology, Immunotherapy : CII|January 1, 1992
Hierarchy of in vitro sensitivity and resistance of tumor cells to cytotoxic effector cells, cytokines, drugs and toxinsJ T Safrit, B Bonavida
Cancer Research|December 1, 1992
Sensitivity of resistant human tumor cell lines to tumor necrosis factor and adriamycin used in combination: correlation between down-regulation of tumor necrosis factor-messenger RNA induction and overcoming resistanceJ T Safrit, B Bonavida
Current Opinion in Immunology|August 1, 1995
The immunology of primary HIV infection: which immune responses control HIV replication?J T Safrit, R A Koup
Journal of Immunology (Baltimore, Md. : 1950)|October 15, 1991
Synergistic effect of tumor necrosis factor-alpha- and diphtheria toxin-mediated cytotoxicity in sensitive and resistant human ovarian tumor cell linesH Morimoto, J T Safrit, B Bonavida
The Journal of Urology|May 1, 1993
Sensitivity of human renal cell carcinoma lines to TNF, adriamycin, and combination: role of TNF mRNA induction in overcoming resistanceJ T Safrit, A Belldegrun, B Bonavida
Gynecologic Oncology|February 1, 1993
Sensitivity of drug-resistant human ovarian tumor cell lines to combined effects of tumor necrosis factor (TNF-alpha) and doxorubicin: failure of the combination to modulate the MDR phenotypeJ T Safrit, J S Berek, B Bonavida
AIDS (London, England)|January 1, 1997
New observations on cellular immune responses to HIV and T-cell epitopesF M Gotch, R A Koup, J T Safrit
Journal of Immunology (Baltimore, Md. : 1950)|October 15, 1994
A region of the third variable loop of HIV-1 gp120 is recognized by HLA-B7-restricted CTLs from two acute seroconversion patientsJ T Safrit, A Y Lee, C A Andrews, et al.
Seminars in Immunology|August 1, 1996
Defining antibody protection against HIV-1 transmission in Hu-PBL-SCID miceR A Koup, J T Safrit, R Weir, et al.
The Journal of Infectious Diseases|May 1, 1995
Pre- and postexposure protection against human immunodeficiency virus type 1 infection mediated by a monoclonal antibodyM C Gauduin, J T Safrit, R Weir, et al.
Pageof 3